Integromics today announces the availability of SeqSolve™, a unique Next Generation Sequencing (NGS) functional bioinformatics analysis software designed for the use by scientists.

Granada and Madrid, Spain and Philadelphia, PA, U.S. – Integromics, a market leader in IT solutions for life sciences in the field of genomics and proteomics, today announces the availability of SeqSolve™, a unique Next Generation Sequencing (NGS) functional bioinformatics analysis software designed for the use by scientists.

The SeqSolve™ analysis software, exclusively designed for Next Generation Sequencing, performs tertiary level analyzes for biologically relevant results. It has been designed with a high performance and robust computational core with a simple, but powerful user interface.

Currently, analyzing data generated by NGS experiments requires considerable amounts of time, money and resources. SeqSolve™ is the first NGS analysis software on the market specifically developed for data interpretation without requiring bioinformatics expertise. SeqSolve™ also allows transcriptomics labs to step into RNA-seq data analysis, saving time and money and enables complete profiling of RNA-seq data. Results are original, biologically relevant, supported by powerful statistics and based on state-of-the-art scientific literature.

The first version of the SeqSolve™ solution features a broad RNA-seq analysis portfolio, including differential gene expression measurement and best-in-class, dynamic and interactive scientific visualizations. It also comes with the exclusive Click and GO® technology and its intelligent quality control system allows complete, automatic and unique profiling of transcriptome data.

“The release of the first version of SeqSolve™ is the initial step of our strategic move into the NGS market. We would like to use our expertise in the transcriptomics field by adding novel, high-relevance features, extreme usability, smooth automation, intelligent quality control and high-impact visualizations to all segments of the growing NGS bioinformatics market.” – said Dr. Michael J. McManus, CEO, Integromics.

The initial analysis with SeqSolve™ was published earlier this year in Nature Journal (Kapranov P. et al. Nature, July 29, 2010), and is the same analysis that can now be automatically performed in minutes on a laptop by the commercial version of SeqSolve™.

About Integromics® S.L.

INTEGROMICS, S.L. provides IT solutions for Life Sciences in the areas of Genomics and Proteomics. In the post-genomic era, Integromics S.L. offers state-of-the-art products, services and training in two strategic areas: data management/integration and intelligent data analysis. The company has developed a network of collaborators both in industry and academia to provide complete technological solutions that will help our clients to achieve their goals. Integromics® S.L. was founded in 2002 and is based in Granada, Spain, with offices in Madrid, Spain. Integromics, Inc., a wholly owned subsidiary that was established in 2007 is based Philadelphia, PA. For more information, visit www.integromics.com